RobertEnochLitmanMD

Geriatric Psychiatry

Associate Professor, Psychiatry, Georgetown University School of Medicine

Dr. Litman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
9605 Medical Center Dr
Suite 270
Rockville, MD 20850
Phone+1 301-251-4702

Fax+1 301-762-5711

National Institutes of Health Clinical CenterResidency, Psychiatry, 1988 - 1989
Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1981 - 1984
Albany Medical CenterInternship, Internal Medicine, 1980 - 1981
Albany Medical CollegeClass of 1980

PubMed

43 citations
Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia.
Kimberly E. Vanover, Robert E. Davis, Yun Zhou, Weiguo Ye, James Robert Brašić
Neuropsychopharmacology. 2019-02-01
56 citations
Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies.
Steven G. Potkin, Robert E. Litman, Rosarelis Torres, Curt D. Wolfgang
Journal of Clinical Psychopharmacology. 2008-04-01
27 citations
The selective neurokinin 3 antagonist AZD2624 does not improve symptoms or cognition in schizophrenia: a proof-of-principle study.
Robert E. Litman, Mark A. Smith, Dhaval G. Desai, Thomas Simpson, Dennis Sweitzer
Journal of Clinical Psychopharmacology. 2014-04-01

Journal Articles

Dopamine D2 Receptor Occupancy of Lumateperone (ITI-007): A Positron Emission Tomography Study in Patients with Schizophrenia
Robert E Litman, Dean F Wong, James R Brasic, Nature